Tenon Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	3.21	2.93	0.69	0.16	0.04
Revenue Growth (YoY)	205.22%	323.73%	331.87%	265.13%	-
Cost of Revenue	1.46	1.69	1.33	0.06	0.02
Gross Profit	1.76	1.24	-0.64	0.11	0.03
Selling, General & Admin	13.11	13.81	15.26	4.85	0.34
Research & Development	3	3.16	2.83	1.72	0.22
Operating Expenses	16.11	16.97	18.08	6.57	0.56
Operating Income	-14.35	-15.73	-18.73	-6.46	-0.54
Interest Expense / Income	0.06	0.02	0.35	0.62	0.17
Other Expense / Income	-0.08	-0.17	-0.16	-0.03	-0.12
Pretax Income	-14.33	-15.58	-18.92	-7.05	-0.59
Net Income	-14.33	-15.58	-18.92	-7.05	-0.59
Shares Outstanding (Basic)	3	2	1	0	0
Shares Outstanding (Diluted)	3	2	1	0	0
Shares Change	153.83%	126.47%	787.04%	8.80%	-
EPS (Basic)	-6.69	-8.59	-23.62	-78.10	-7.10
EPS (Diluted)	-6.69	-8.59	-23.62	-78.10	-7.10
Free Cash Flow	-11.34	-12.54	-12.87	-4.39	-0.17
Free Cash Flow Per Share	-3.98	-6.92	-16.07	-48.66	-2.02
Gross Margin	54.70%	42.38%	-92.76%	65.63%	58.34%
Operating Margin	-446.39%	-537.12%	-2709.84%	-4038.13%	-1223.85%
Profit Margin	-445.77%	-532.14%	-2737.63%	-4405.00%	-1335.41%
Free Cash Flow Margin	-352.86%	-428.42%	-1862.81%	-2746.25%	-381.93%
EBITDA	-13.77	-15.13	-18.27	-6.31	-0.42
EBITDA Margin	-428.31%	-516.87%	-2644.57%	-3945.62%	-952.38%
Depreciation & Amortization	0.51	0.43	0.29	0.11	0
EBIT	-14.27	-15.56	-18.56	-6.43	-0.42
EBIT Margin	-444.06%	-531.42%	-2686.40%	-4016.88%	-952.38%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).